Article citationsMore>>
Malfertheiner, P., Megraud, F., O’Morain, C.A., Gisbert, J.P., Kuipers, E.J., Axon, A.T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D.Y., Hunt, R., Moayyedi, P., Rokkas, T., Rugge, M., Selgrad, M., Suerbaum, S., Sugano, K., El-Omar, E.M., on behalf of the European Helicobacter and Microbiota Study Group and Consensus panel (2017) Management of Helicobacter pylori Infection—The Maastricht V/Florence Consensus Report. Gut, 66, 6-30.
https://doi.org/10.1136/gutjnl-2016-312288
has been cited by the following article:
-
TITLE:
Clinical Efficacy of Prolonged First-Line Treatment against Helicobacter pylori in Ouagadougou
AUTHORS:
Nômawendé Inès Compaore, Couna Christiane Some, Nanelin Alice Guingane, Tegwinde Rebeca Compaore, Marie Nina Compaore, Roger Sombie, Alain Bougouma
KEYWORDS:
Helicobacter pylori, Treatment Efficacy, Triple Therapies, Quadritherapy
JOURNAL NAME:
Open Journal of Gastroenterology,
Vol.12 No.7,
July
27,
2022
ABSTRACT: Background: Helicobacter pylori (H. pylori) infection is a public health concern. In fact, due to bacterial resistance, treatment strategy is a challenge. It is then more recommended to prolong first-line treatment. In order to be acceptable, the clinical efficacy of treatment must be higher than 90%. Aim: We aimed to assess the outcome of prolonged first-line treatment among adults. Patients and Methods: The study was cross-sectional among adults and patients were treated for H. pylori eradication for the first time during 10 to 14 days. Recruitment was made from March 2019 in six private polyclinics and two hospitals of the city of Ouagadougou. We used monoclonal antigen (Ag) test on the stool samples for diagnostic and for the patients follow up. Chi squared (X2) tests and ANOVA for the comparison of percentages and means were determined using with STATA®software program in the bilateral 95% confidence interval for the statistical analysis. Results: In the different medical centers for 19 months, 365 patients were compiled. The sex-ratio was 0.64. The average age was 43.55 years. The treatment efficacy was 92.88%. Treatment efficacy was better with p-value -3 depending on prescriber: gastroenterologist (94.07%), general practitioner (75%); compliance before treatment: excellent (95.88%) or bad (50%); number of consultations: ≥four (94.35%), three (96.32%), two (78.85%). Triple therapies efficacy was 90.81%; p = 0.19. Quadritherapy efficacy was 95%; p = 0.5. Conclusion: This research is a contribution to the advent of national or African recommendations.
Related Articles:
-
Ngala Akoa Itoua-Ngaporo, Lucie C. A. I. O. Ikobo, Arnaud Mongo-Onkouo, Jile Florent Mimiesse Monamou, Clausina Philestine Ahoui Apendi, Rody Stéphane Ngami, Marlyse Ngalessami Mouakosso, Deby Gassaye, Blaise Irenée Atipo Ibara, Jean-Rosaire Ibara
-
M. Elmahdy, Sameh S. Sadek, A. Elmarsafawy, D. Elkafash, Azza Elhenawy
-
Bienvenu H. Atipo-Ibara, Anicet Boumba, Lucie C. Atipo Ibara Ollandzobo Ikobo, Arnaud Mongo-Onkouo, Jile F. Mimiesse Monamou, Ngala A. Itoua-Ngaporo, Donatien Moukassa, Blaise I. Atipo Ibara, Jean-Rosaire Ibara
-
Sahwa Ahmed Ali, Nasr Eldeen Ali Mohammed Gaufri
-
Flavio Gimenes Alvarenga, Mahouton Jonas Stephane Houndjo, Adjimon Vincent Monwanou, Jean Bio Chabi Orou